Skip to main content
VulnerabilityPublished

CVE-2026-105704: SourceCodester Drug Recommendation System · Improper Authentication

Affects SourceCodester Drug Recommendation SystemSource CVE Database V5

0
Compare

Public exploit available · CVSS 6.9 Medium.

Data as of 20 Nov 2026, 17:34 UTC

CVSS 4.0 base score
6.9Medium
How severe the flaw is on the 0–10 CVSS scale.
EPSS
0.3% chance of exploitation in 30 days – higher than 34% of CVEsExploit Prediction Scoring System: the likelihood attackers will use this flaw soon.
CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:L/VI:L/VA:L/SC:N/SI:N/SA:N/E:P

Exploitation evidence

  1. Disclosed: evidence found.

    CVE published 6 Oct 2026

  2. Detectable: no evidence on record.

    No public nuclei template indexed

  3. Weaponized: evidence found.

    CVSS exploit maturity: proof of concept public

  4. Exploited in the wild: no evidence on record.

    Not in CISA KEV and no source reports exploitation

  5. Observed by OffSeq Mirage: no evidence on record.

    No attack traffic recorded by OffSeq Mirage sensors

A missing step is not evidence of safety. Sources: cve.org (opens in a new tab), CVSS vector, the Metasploit, Exploit-DB and nuclei-templates index as of 20 Nov 2026.

What to do

Affected software

ProductAffectedFixed in
SourceCodesterDrug Recommendation SystemAffected
  • =1.0
Fixed in–

CPE configurations (1)

  • cpe:2.3:a:sourcecodester:drug_recommendation_system:*:*:*:*:*:*:*:*

AI-suggested

Until an official fix is available, restrict access to the affected system and monitor for suspicious activity related to authentication bypass attempts. Avoid exposing the vulnerable system to untrusted networks where possible.

Description

A vulnerability was identified in SourceCodester Drug Recommendation System 1.0. This affects an unknown function of the component Auth Guard. Such manipulation of the argument user_id leads to improper authentication. The attack can be executed remotely. The exploit is publicly available and might be used.

References

Community reviews

Loading reviews…